Gastrointestinal Stent Market

The gastrointestinal stent market is projected to reach USD 0.82 billion by 2031 from USD 0.62 billion in 2026, growing at a CAGR of 5.7% during the forecast period.

The gastrointestinal stent market is currently booming. This is mainly due to the increasing number of gastrointestinal disease cases, which in turn is generating a need for treatment options that are effective and also less invasive. Many cancers, such as those of the esophagus, colorectum, and stomach, are contributing to the rise, along with other diseases and complications of the digestive system. In addition to medical conditions, advances in stent technology played a key role in driving up demand. For instance, self-expanding metal stents (SEMS), biodegradable stents, and drug-eluting stents have all been great help in eliminating the discomfort patients suffer from most invasive surgeries. Manufacturers are even more motivated to provide innovative stent solutions as a result of the increasing healthcare spending and the efforts made by governments to provide access to better medical care. Simultaneously, these devices are becoming the preferred therapeutic option to meet the rising needs of efficient management of gastrointestinal diseases.

To know about the assumptions considered for the study download the pdf brochure

The prominent players in the gastrointestinal stent market are Boston Scientific Corporation (US), Cook (US), Medtronic (Ireland), Olympus Corporation (Japan), BD (US), among others. These companies have implemented a variety of growth strategies, both organic and inorganic, including the introduction of new products, the formation of strategic partnerships, and penetration into emerging markets. These initiatives are aimed at enhancing their market share and diversifying their portfolios.

In October 2025, Boston Scientific Corporation (US) announced that it had received 510(k) clearance from the U.S. Food and Drug Administration and CE Mark approval to market its Advanix Biliary Plastic Stents for the treatment of biliary strictures, including biliary stone disease, benign biliary strictures, and suspected and confirmed malignancies in the biliary system.

In January 2024, Olympus Corporation (Japan) announced the completion of its acquisition of Taewoong Medical, a South Korea-based manufacturer of gastrointestinal metallic stents. With Taewoong now operating as a subsidiary, Olympus aims to strengthen its GI EndoTherapy portfolio, enhance comprehensive treatment solutions, and improve patient outcomes.

Boston Scientific Corporation is a global medical technology company that develops, manufactures, and commercializes a broad range of medical devices used in interventional medical specialties, including cardiovascular, endoscopy, urology, and neuromodulation. The company operates through two primary segments, MedSurg and Cardiovascular, offering products for minimally invasive procedures to diagnose and treat a wide range of conditions, including gastrointestinal, cardiac, and pulmonary diseases. Its portfolio includes devices such as stents, catheters, imaging systems, and endoscopic technologies aimed at improving clinical outcomes and patient quality of life. Boston Scientific has a strong global presence, with operations and product distribution across North America, Europe, Asia Pacific, and emerging markets, supported by ongoing investment in innovation and clinical research to advance less-invasive treatment solutions.

Cook is a global medical device company that develops, manufactures, and distributes minimally invasive medical technologies used across a wide range of clinical specialties, including vascular, endoscopy, urology, critical care, and interventional radiology. The company focuses on delivering innovative devices that address unmet clinical needs and improve patient outcomes. Its product portfolio includes stents, catheters, guidewires, and other interventional devices designed to support diagnostic and therapeutic procedures. Cook Medical emphasizes close collaboration with healthcare professionals to drive innovation and enhance clinical practice. The company has a strong global footprint, with operations and product distribution across North America, Europe, Asia Pacific, and other international markets, supported by a broad manufacturing and supply network and a long-standing focus on minimally invasive care solutions.

Market Ranking

The top five companies of the gastrointestinal stent market are Boston Scientific Corporation (US), Cook (US), Medtronic (Ireland), Olympus Corporation (Japan), and BD (US). Boston Scientific Corporation (US) offers a wide range of gastrointestinal stents, including esophageal, biliary, and lumen-apposing metal stents, designed for minimally invasive management of strictures, obstructions, and fluid collections with enhanced deliverability and anti-migration features. Cook (US) provides an extensive portfolio of GI stents, including esophageal, biliary, colonic, and duodenal stents, with a focus on physician-driven designs featuring controlled deployment and optimal radial force to improve clinical outcomes. Medtronic (Ireland) delivers minimally invasive gastrointestinal solutions through its broader therapy portfolio, supporting endoscopic procedures with advanced delivery systems and integrated technologies for effective disease management. Olympus Corporation (Japan) offers gastrointestinal stents within its EndoTherapy segment, including esophageal and biliary metallic stents, strengthened by its acquisition of Taewoong Medical to expand product capabilities and clinical applications. BD (US) provides interventional and endoscopic solutions that complement gastrointestinal procedures, focusing on procedural efficiency, safety, and integrated systems that support stent-based therapies.

Related Reports:

Gastrointestinal Stent Market By Product (Duodenal, Pancreatic, Colonic, Biliary), Type [Metal (SEMS, Balloon-expandable, Nitinol, Stainless Steel), Plastic, Biodegradable], Application (Colorectal & Stomach Cancer), End User - Global Forecast to 2031

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]